VOR - Vor Biopharma Inc.

QQQ $ 472.49 $ -2.05 (-0.43 %)

DIA $ 416.26 $ -1.07 (-0.26 %)

SPY $ 562.20 $ -1.67 (-0.3 %)

TLT $ 99.62 $ -1.25 (-1.24 %)

GLD $ 235.53 $ -1.83 (-0.77 %)

Previous Close

$ 0.9342

Open

$ 0.96

Bid

$ 0.93 x 400

Ask

-- x --

Day's Range

$ 0.92 - $ 0.99

52 Week Range

$ 0.70 - $ 3.14

Volume

672,591

Average Volume

Market Cap

63.9M

Beta (5Y Monthly)

$ 0.56

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	03-20-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-11-2023	03-31-2023	10-Q
7	03-23-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-11-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-14-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-25-2021	12-31-2020	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-oracle-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket

Why Oracle Shares Are Trading Higher By Ar...
09/10/2024 10:41:15

JMP Securities Reiterates Market Outperfor...
09/06/2024 14:52:07

JMP Securities analyst Silvan Tuerkcan reiterates Vor Biopharma (NASDAQ:VOR) with a Market Outperform and maintains $12 pric...

whats-going-on-with-penny-stock-blood-cancer-focused-vor-biopharma-on-friday

What's Going On With Penny Stock Blood Can...
09/06/2024 13:35:08

Vor Biopharma reveals promising Phase 1/2 study results for AML treatment, and it is planning FDA pivotal trial discussions.

HC Wainwright & Co. Reiterates Buy on Vor ...
09/06/2024 10:28:59

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vor Biopharma (NASDAQ:VOR) with a Buy and maintains $17.5 ...

why-argan-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket

Why Argan Shares Are Trading Higher By Aro...
09/06/2024 09:41:54

Vor Bio Releases New Clinical Data Confirm...
09/06/2024 06:44:37

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefit VCAR33ALLO demons...

Vor Bio New Clinical Data Validates Its Ap...
09/05/2024 20:03:52

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefitVCAR33ALLO demonstrat...

Barclays Maintains Overweight on Vor Bioph...
08/14/2024 15:20:37

Barclays analyst Carter Gould maintains Vor Biopharma (NASDAQ:VOR) with a Overweight and lowers the price target from $10 to...

Vor Biopharma Q2 EPS $(0.41) Beats $(0.42)...
08/08/2024 21:57:16

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.42) ...

JMP Securities Reiterates Market Outperfor...
05/13/2024 15:39:16

JMP Securities analyst Silvan Tuerkcan reiterates Vor Biopharma (NASDAQ:VOR) with a Market Outperform and maintains $12 pric...

Oppenheimer Reiterates Outperform on Vor B...
05/13/2024 12:40:54

Oppenheimer analyst Matthew Biegler reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and lowers the price target from...

Wedbush Reiterates Outperform on Vor Bioph...
05/10/2024 13:49:05

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and maintains $11 price target.

Vor Biopharma Q1 2024 GAAP EPS $(0.45) Mis...
05/09/2024 21:00:23

Vor Biopharma (NASDAQ:VOR) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.37...

Wedbush Reiterates Outperform on Vor Bioph...
04/23/2024 17:24:12

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and maintains $11 price target.

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/05/2024 20:31:09

JMP Securities Reiterates Market Outperfor...
03/22/2024 17:13:57

JMP Securities analyst Silvan Tuerkcan reiterates Vor Biopharma (NASDAQ:VOR) with a Market Outperform and maintains $12 pric...

Stifel Maintains Buy on Vor Biopharma, Low...
03/21/2024 13:39:11

Stifel analyst Stephen Willey maintains Vor Biopharma (NASDAQ:VOR) with a Buy and lowers the price target from $15 to $12.

Wedbush Reiterates Outperform on Vor Bioph...
03/21/2024 13:14:24

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and maintains $11 price target.

Oppenheimer Reiterates Outperform on Vor B...
03/21/2024 13:02:18

Oppenheimer analyst Matthew Biegler reiterates Vor Biopharma (NASDAQ:VOR) with a Outperform and lowers the price target from...

HC Wainwright & Co. Reiterates Buy on Vor ...
03/21/2024 10:44:06

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Vor Biopharma (NASDAQ:VOR) with a Buy and maintains $17.5 ...